Trademarkia Logo

About 5 Trademarks found for “GVOKE”

Filters

Also try searching for:

GVOKE*

GVOK*

*OKE

GV*KE

2126390
REGISTERED

on 25 Jan 2023

Gvoke

Xeris Pharmaceuticals, Inc.

2126390 · 5 Mar 2021

044

Providing information on the topics of diabetes and pharmaceuticals fo...

2380810
REGISTERED

on 25 Jan 2023

Gvoke

Xeris Pharmaceuticals, Inc.

2380810 · 5 Mar 2021

005

Pharmaceutical products for the treatment of diabetes and metabolic di...

1936992
REGISTERED

on 3 Aug 2022

GVOKE

XERIS PHARMACEUTICALS INC.

1936992 · 19 Dec 2018

005

010

Pharmaceutical products for the treatment of diabetes and metabolic di...

2320951
FORMALIZED

on 10 Apr 2024

GVOKE VIALDX

Xeris Pharmaceuticals, Inc.

2320951 · 9 Feb 2024

005

044

Pharmaceutical preparations for in vivo diagnostic use; pharmaceutical...

1936993
REGISTERED

on 3 Aug 2022

GVOKE HYPOPEN

XERIS PHARMACEUTICALS INC.

1936993 · 19 Dec 2018

005

010

Pharmaceutical products for the treatment of diabetes and metabolic di...

Owners

Xeris pharmaceuticals, inc. (3)

Xeris pharmaceuticals inc. (2)

Categories

Class 5 (4)

Class 10 (2)

Class 44 (2)

Correspondents

Norton rose fulbright canada llp/s.E.N.C.R.L.,s.R.L. (3)

Osler, hoskin & harcourt llp (1)

End of search results

Page 1 of 1

This website uses cookies

We use cookies to ensure you get the best experience. Check our Privacy Policy and Terms & Conditions.
Manage cookies

Manage cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.